SKU: B002  / 
    CAS Number: 1405-87-4

    Bacitracin, USP

    $62.00 - $263.00

    Bacitracin is a branched cyclic dodecylpeptide antibiotic produced by Bacillus licheniformis and some strains of Bacillus subtilis (Azevedo et al 1993).  It is synthesized as a mixture of up to 50 closely related congeners/fractions.  Bacitracin includes the following fractions: A, B1, B, B2, B3, C, C1, C2, C3, D, E, F, G, H1, H2, H3, I1, I2, I3, and X. 

    Bacitracin is freely soluble in aqueous solution.

    Bacitracin is a polypeptide antibiotic, a mixture composed of related cyclic peptides made by Bacillus licheniformis first isolated in 1945 from the 'Tracy I' variety (ATCC 10716).  It was isolated by Balbina Johnson, a bacteriologist at Columbia University. Bacitracin can be synthesized via nonribosomal peptide synthetases (NRPSs).  The three-enzyme operon is called BacABC.

    For more Bacitracin products, click here.

    Mechanism of Action Bacitracin prevents phosphorylation of bactoprenol, a transport protein which carries peptidoglycan components outside the cell membrane. Without the active phosphorylated bactoprenol, peptidoglycan synthesis cannot be completed and the cell lyses. Resistance to Bacitracin is understood to involve two mechanisms: A protein transporter (BcrABC) which pumps bacitracin out of the cell after it has entered, and via another protein (BacA) which provides the active phosphorylated bactoprenol from a different synthetic pathway.
    Spectrum Bacitracin inhibits cell wall synthesis in Gram-positive bacteria including Streptococcus pyogenes and Staphylococcus aureus. Representative MIC values include:
    • Staphylococcus aureus 2µg/mL - >32 µg/mL
    • Streptococcus agalactiae >16 µg/mL (Group B)
    • For a representative list of Bacitracin MIC values, click here.
    Impurity Profile Composition
    Content of Bacitracin A: ≥ 40.0%
    Content of active Bacitracin: ≥ 70.0% of total area
    Limit of early eluting peptides: ≤ 20.0%
    Limit of Bacitracin F: ≤ 6.0%
    Microbiology Applications Bacitracin is a useful tool to differentiate between ß-hemolytic, group A Streptococci (Streptococcus pyogenes) and ß-hemolytic Streptocococci of other groups. Bacitracin can be used as a supplement in chocolate agar to facilitate the isolation of Haemophilus influenzae. Bacitracin can be used to study the regulatory network in B. subtilis. By systematically analyzing the Bacitracin stimulon, authors can pinpoint the loci induced by Bacitracin (Mascher et al 2003).
    Plant Biology Applications Tobacco hairy roots and cell suspensions were used in plant transformation studies to produce full length murine IgG1 monoclonal antibody. Bacitracin has been shown to prevent degradation of peptides and hormones in plant systems. Treatment with Bacitracin was not sufficient to prevent loss of antibody from the cultures, but improved the growth rates by up to 53% (Sharp and Doran, 1999).
    Molecular Formula C66H103N17O16S
    Source Bacillus subtilis and B. licheniformis
    References Bell, RG (1992) Preparative high-performance liquid chromatographic separation and isolation of Bacitracin components and their relationship to microbiological activity. J. Chromatog. 590:163-68

    Cain BD, Norton PG, Eubanks W, Nick HS and Allen CM (1993) Amplification of the bacA gene confers bacitracin resistance to Escherichia coli. J. Bacteriol. 175(12):3784-3789 PMID 8389741

    Jacobsen C et al (2015) Regulation of tissue factor in NT2 germ cell tumor cells by cisplatin chemotherapy. Thromb Res. 136(3):673-681 PMID 26205155

    Langer F et al (2013) Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase. Blood 121 (12):2324-2335 PMID 23315166

    Mascher T, Margulis NG, Wang T, Ye RW, Helmann JD (2003) Cell wall stress responses in Bacillus subtilis: The regulatory network of the bacitracin stimulon. Mol. Microbiol 50(5):1591-1604 PMID 14651641

    Mueller MJ, Brodschelm W (1993) Signaling in the elicitation process is mediated through the octadecanoid pathway leading to jasmonic acid. Proc. Natl. Acad. Sci. 90:7490-7494 PMID 11607420

    Sharp, JM and Doran, PM (1999) Effect of Bacitracin on growth and monoclonal antibody production by tobacco hairy roots and cell suspensions. Biotechnol. Bioprocess Eng. 4:253

    Stone KJ and Strominger JL (1971) Mechanism of action of Bacitracin: Complexation with metal ion and C55-isoprenyl pyrophosphate. PNAS 68 (12): 3223-3227 PMID 4332017

    Webb NE  (2015) Dose-response models reveal critical features of inhibitor activity and viral infection. phD dissertation. UCLA
    MIC Bacteroides fragilis| >8|| Clostridium difficile| >256|| Clostridium perfringens| 0.25|| Clostridium spiroforme| 4 - >8|| Diplococcus pneumoniae| 0.04 - 12.5|| Enterococcus faecium| ≤1120 - ?|| Escherichia coli| >8 - 1560|| Fusarium oxysporum| 55|| Fusobacterium necrophorum| 9.4 - 100|| Haemophilus influenzae| >16 - 400|| Listeria innocua| 50|| Listeria monocytogenes (FBUNT)| 32|| Listeria spp.| ≤8 - >128|| Moraxella catarrhalis| 1 - 4|| Neisseria gonorrhoeae| 800|| Penicilium oxallicum | 50|| Propionibacterium freudenreichii | <1|| Proteus vulgaris| 700|| Pseudomonas aeruginosa| 700|| Salmonella Agona (14749 + serovar B)| 3120|| Salmonella Anatum (12453 + serovar E)| 3120|| Salmonella Brandenburg (15865 + serovar B)| 3120|| Salmonella Cerro| 1560|| Salmonella Choleraesuis (12630 + serovar C1)| 3120|| Salmonella Dublin| 1560 - 3120|| Salmonella Give| 3120|| Salmonella Muenster| 3120|| Salmonella Newport (12418 + serovar C2)| 3120|| Salmonella Ohio (14497 + serovar C1)| 3120|| Salmonella Stanley (17031 + serovar E)| 3120|| Salmonella typhimurium| ≤1120 - 3120|| Staphylococcus aureus| ≤0.03 - 700|| Staphylococcus auricularis| 0.25 - 128|| Staphylococcus capitis| 0.25 - >128|| Staphylococcus caprae| 16|| Staphylococcus cohnii| >128|| Staphylococcus epidermidis| 0.25 - >16|| Staphylococcus haemolyticus| 0.25 - >128|| Staphylococcus hominis| 0.25 - 16|| Staphylococcus intermedius | 0.25 - 128|| Staphylococcus lugdunensis| 0.25 - >4|| Staphylococcus pyogenes (erythromycin-resistant)| 0.25 - >4|| Staphylococcus saprophyticus| 0.25 - >128|| Staphylococcus sciuri| 16|| Staphylococcus simulans| 0.25 - 128|| Staphylococcus warneri | 0.25 - >128|| Staphylococcus xylosus (LQC 5156)| >128|| Streptococci (Viridans group)| 2 - >16|| Streptococcus agalactiae| 2 - >16|| Streptococcus faecium| 850|| Streptococcus pneumonia| 0.06 - >16|| Streptococcus pyogenes| 0.5 - >16|| Treponema hyodysenteriae | 12.5 - 50||